Inventor · disambiguated record
Fritz Eckstein
Also filed as: ECKSTEIN FRITZ
12 granted patents·1 pending application·1,015 citations·filing 1977–2003
94Inventor score
Top patents by PatentIndex Score
13 records- 0196US5672695AModified ribozymesMAX PLANCK GESELLSCHAFT·Filed 1991·Granted Sep 30, 1997·382 cites·26 claims
- 0291US6127173ANucleic acid catalysts with endonuclease activityRIBOZYME PHARM INC·Filed 1998·Granted Oct 3, 2000·194 cites·28 claims
- 0390US5698687AModified ribozymlsMAX PLANCK GESELLSCHAFT·Filed 1995·Granted Dec 16, 1997·95 cites·37 claims
- 0489US5891725ASynthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing themYISSUM RES DEV CO·Filed 1993·Granted Apr 6, 1999·141 cites·11 claims
- 0587US4880782AMethod of treating viral infections in humans and compositions thereforMAX PLANCK GESELLSCHAFT·Filed 1987·Granted Nov 14, 1989·53 cites·12 claims
- 0686US5817635AModified ribozymesMAX PLANCK GES EV·Filed 1995·Granted Oct 6, 1998·88 cites·42 claims
- 0784US4145531AProcess for producing 2'-substituted-D-ribofuranosyl purine compoundsMAX PLANCK GESELLSCHAFT·Filed 1977·Granted Mar 20, 1979·25 cites·11 claims
- 0880US6656731B1Nucleic acid catalysts with endonuclease activityMAX PLANCK GESELLSCHAFT·Filed 2000·Granted Dec 2, 2003·10 cites·50 claims
- 0957US6110742ASynthetic antisense oligodeoxynucleotides targeted to AChEYISSUM RES DEV CO·Filed 1997·Granted Aug 29, 2000·12 cites·8 claims
- 1040US6890908B1Modified ribozymesMAX PLANCK GESELLSCHAFT·Filed 1997·Granted May 10, 2005·2 cites·14 claims
- 1140US6121046ASynthetic antisense oligodeoxynucleotides targeted to human acheYISSUM RES DEV CO·Filed 1997·Granted Sep 19, 2000·4 cites·14 claims
- 1240US4331662AMethods for the treatment of viral infectionsMAX PLANCK GESELLSCHAFT·Filed 1980·Granted May 25, 1982·9 cites·1 claims
- 1340US2006036087A12'-deoxy-2'-fluoro modified RNARIBOZYME PHARM INC·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fritz Eckstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →